PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,649 | +58.4% | 23,143 | +126.7% | 0.00% | – |
Q2 2023 | $24,397 | -83.2% | 10,208 | -78.2% | 0.00% | – |
Q1 2023 | $145,349 | +231.8% | 46,887 | +186.8% | 0.00% | – |
Q4 2022 | $43,812 | -91.3% | 16,348 | -90.4% | 0.00% | – |
Q3 2022 | $505,000 | -29.0% | 170,522 | -29.7% | 0.00% | – |
Q2 2022 | $711,000 | -65.8% | 242,571 | -40.3% | 0.00% | – |
Q1 2022 | $2,076,000 | -28.2% | 406,248 | -5.2% | 0.00% | -100.0% |
Q4 2021 | $2,892,000 | +20.6% | 428,366 | +23.7% | 0.00% | – |
Q3 2021 | $2,398,000 | -30.3% | 346,431 | -2.0% | 0.00% | -100.0% |
Q2 2021 | $3,441,000 | -9.5% | 353,321 | +46.3% | 0.00% | 0.0% |
Q1 2021 | $3,801,000 | – | 241,514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,208,472 | $64,752,000 | 13.08% |
Ikarian Capital, LLC | 527,964 | $15,480,000 | 1.23% |
Abingworth LLP | 53,612 | $3,001,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 432,670 | $12,686,000 | 0.37% |
Eversept Partners, LP | 46,310 | $1,357,809 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 44,024 | $1,291,000 | 0.09% |
KNOTT DAVID M | 3,835 | $112,000 | 0.06% |
Baker Brothers Advisors | 199,671 | $5,854,000 | 0.03% |
HRT FINANCIAL LP | 7,339 | $215,000 | 0.01% |
Renaissance Technologies | 29,986 | $879,000 | 0.00% |